Koo,

Don't count your chickens before they hatch. We're still waiting for the BETonMACE eggs to crack. Let's wait and see what the main cardio and renal/cognition sub-studies shows before getting too excited about a couple of sentences from an analyst report about a potential follow-on cognition trial. As for the number of patients in the cognition sub-study......the AAIC poster had more details. ~500 patients had the MoCA test, but only about half that had the baseline MoCA < 25 to be eligible for the cognition sub-study. Should be approximately half apabetalone, half placebo.

BearDownAZ